e-drug
[Top] [All Lists]

[e-drug] Losartan: seizure in the Netherlands, marketing in Switzerland

E-DRUG: Losartan: seizure in the Netherlands, marketing in Switzerland
---------------------------------------

Dear all,

The company Mepha Pharma - the No 1 generic producer in Switzerland - has been 
granted a license by Merck Sharp & Dohme (MSD) to market in Switzerland a 
generic version of the Active Pharmaceutical Ingredient Losartan Potassium, 
i.e. the same API contained in the generic Indian drug that has been seized by 
the Dutch customs authorities last December whilst transiting from India to 
Brazil. 

Mepha issued a press release last week on the subject (available in French or 
German only 
(http://www.mepha.ch/sites/fr/medias/Documents/Communiqu%C3%A9%20de%20presse%20Losartan-Mepha.pdf),
 highlighting that the cooperation with MSD is taking place while the patent of 
the original product is still valid until the end of the year for the single 
preparation (losartan potassium, Cozaar), and until the end of 2012 for the 
combined preparation (losartan potassium combined with diuretic, Hyzaar).

If and how far these two issues are linked remains to be seen.

Patrick Durisch
-----
Déclaration de Berne - Berne Declaration
Patrick Durisch
Santé & Environnement - Health & Environment
Rue de Genève 52, CH - 1004 Lausanne
Tel. direct: +41 21 620 03 06
Fax: +41 21 620 03 00
Email: durisch@ladb.ch 
Web: www.ladb.ch 

Recherche pharmaceutique et maladies du Sud : Remédier à une négligence 
coupable Commandez cette nouvelle brochure thématique de la DB.
http://www.evb.ch/fr/p25014645.html 


<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Losartan: seizure in the Netherlands, marketing in Switzerland, Patrick Durisch <=